• In Vitro Susceptibility of Staphylococci to Mupirocin and No

  2026-05-15

  This study evaluates the in vitro activity of mupirocin and novobiocin against meticillin-resistant and meticillin-susceptible staphylococci from dogs, highlighting key resistance trends and methodology. Its findings inform antimicrobial selection for veterinary dermatology and provide a comparative framework for in vitro antibacterial testing strategies.

• Merimepodib (VX-497): Precision IMPDH Inhibition in Antivira

  2026-05-15

  Merimepodib (VX-497) empowers researchers to selectively target guanine nucleotide biosynthesis, delivering robust inhibition of cell proliferation and viral replication. With validated, cross-species efficacy and unique workflow flexibility, it unlocks new possibilities for cancer, immunology, and virology experiments—especially where specificity and reversibility are critical.

• N3-kethoxal: Precision Mapping of RNA Structures and Genomic

  2026-05-14

  N3-kethoxal, a membrane-permeable azide-functionalized nucleic acid probe, enables high-resolution, covalent labeling of unpaired guanine bases in both RNA and DNA for advanced structural and functional genomic studies. Its versatility spans in vitro and live-cell assays, supporting cutting-edge applications from RNA secondary structure probing to direct mapping of accessible genomic DNA. This article provides proven workflows, troubleshooting strategies, and evidence-based protocol parameters to maximize assay reliability and reproducibility.

• Paclitaxel (Taxol): Defining Selectivity and Potency in Canc

  2026-05-14

  Explore how Paclitaxel (Taxol) delivers unmatched selectivity and potency in cancer research, with a unique focus on assay precision and translational impact. Discover how its mechanistic clarity and validated parameters set the gold standard for experimental design.

• Autophagy–Metastasis Prognostic Signature in Colorectal Canc

  2026-05-13

  Bai et al. (2026) developed and validated a prognostic signature comprising six genes related to autophagy and liver metastasis in colorectal cancer. Integrating bulk and single-cell transcriptomics, this signature predicts clinical outcomes, immune microenvironment remodeling, and potential therapeutic resistance, advancing precision oncology for CRC patients.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus: Reliab

  2026-05-13

  This article addresses common laboratory challenges in mRNA synthesis, focusing on workflow reliability, translational efficiency, and data reproducibility. Using scenario-driven Q&A, we demonstrate how the HyperScribe™ Co-transcription mRNA Synthesis Kit Plus (ARCA, T7) (SKU K1406) offers robust, evidence-backed solutions for advanced RNA research, including RNA vaccine development and in vitro translation assays.

• Chlorpromazine HCl: Translational Leverage Beyond Dopamine

  2026-05-12

  This thought-leadership article explores how Chlorpromazine HCl, a phenothiazine dopamine receptor antagonist, not only advances psychotic disorder research but also emerges as a tool for host-directed antibacterial strategies. Drawing on recent mechanistic evidence, we guide translational researchers in leveraging Chlorpromazine HCl for both neuropharmacology and innovative infection models, highlighting APExBIO’s leading role in supplying research-grade compounds.

• Technical Guidance for Angiotensin I/II (1-5) in RAS Researc

  2026-05-12

  Angiotensin I/II (1-5) provides the defined Asp-Arg-Val-Tyr-Ile peptide fragment essential for modeling blood pressure regulation and aldosterone stimulation within the renin-angiotensin system. It is appropriate for cardiovascular and renal workflows, but should not be used outside these research contexts. Adherence to its solubility and storage requirements is critical for reproducibility.

• Chlorpromazine HCl: Mechanistic Insight for Translational Re

  2026-05-11

  Explore how Chlorpromazine HCl, a classic dopamine receptor antagonist, enables advanced translational research across neuropharmacology and infection models. This article offers mechanistic depth, evidence-based guidance, and strategic context—bridging foundational neuroscience with host-pathogen investigations. It also positions APExBIO’s Chlorpromazine HCl as a benchmark reagent for experimental rigor and cross-domain innovation.

• Intestinal TM6SF2 Modulates Gut–Liver Axis to Prevent MASH

  2026-05-11

  This study identifies intestinal TM6SF2 as a key regulator that protects against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and modulating lipid-driven gut–liver signaling. The findings suggest that targeting intestinal lipid handling and LPA signaling may offer new therapeutic avenues for MASH.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In

  2026-05-10

  Wang et al. (2018) systematically analyzed the entry mechanism of genotype III grass carp reovirus (GCRV104) in host cells, identifying clathrin-mediated, pH-dependent endocytosis as essential for infection. Their pharmacological inhibitor screen clarified which pathways are critical for viral entry, informing targeted research into host-virus interactions in aquaculture virology.

• Scenario-Driven Solutions with JNK-IN-7 in Apoptosis Assays

  2026-05-09

  This article uses five real laboratory scenarios to illustrate how JNK-IN-7 (SKU A3519) delivers reproducible, data-backed results in cell viability and apoptosis assays. Learn why researchers trust this selective JNK inhibitor for MAPK pathway studies, with evidence-based guidance and direct comparison to alternatives.

• Applied Workflows with Protoporphyrin IX: Photodynamic Compo

  2026-05-09

  Protoporphyrin IX is not just a heme biosynthetic intermediate—it is a cornerstone for advanced photodynamic cancer diagnosis and ferroptosis research. Discover evidence-backed, stepwise protocols, troubleshooting tips, and the latest innovations, including practical translation from the METTL16-SENP3-LTF axis study, to optimize your experimental outcomes with APExBIO’s high-purity reagent.

• Macrophage M1 Polarization via TLR4 in Colitis-Linked Cancer

  2026-05-08

  Liu et al. reveal that Jiedu Xiaozheng Yin (JXY) suppresses colitis-associated colorectal cancer progression by promoting macrophage polarization toward the anti-tumorigenic M1 phenotype through the TLR4 pathway. This work highlights the relevance of immune microenvironment modulation for chemopreventive strategies and provides data-driven insight into pathway-specific interventions.

• Rapid Purification of Recombinant Annexin V for Biophysical

  2026-05-07

  This study introduces a streamlined, calcium-dependent method for purifying recombinant annexin V to high purity, enabling advanced biophysical analyses. The protocol overcomes major contamination issues seen in bacterial expression systems and supports applications such as ion channel characterization and structural biology.

15624 records 1/1042 page Next 12345 下5页 Last page